Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia.
Saved in:
| Title: | Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Hu, Guan-hua1 (AUTHOR), Zuo, Ying-xi2 (AUTHOR), Zhang, Xiao-hui2 (AUTHOR), Wang, Yu2 (AUTHOR), Xu, Lan-ping2 (AUTHOR), Xin-lin, Hou1 (AUTHOR) houxinlin66@163.com, Cheng, Yi-fei2 (AUTHOR) yifeicheng1999@vip.sina.cn, Xiao-jun, Huang2 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Mar2026, Vol. 67 Issue 4, p846-852. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 192477572 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hu%2C+Guan-hua%22">Hu, Guan-hua</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zuo%2C+Ying-xi%22">Zuo, Ying-xi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Xiao-hui%22">Zhang, Xiao-hui</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Yu%22">Wang, Yu</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Lan-ping%22">Xu, Lan-ping</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xin-lin%2C+Hou%22">Xin-lin, Hou</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> houxinlin66@163.com</i><br /><searchLink fieldCode="AR" term="%22Cheng%2C+Yi-fei%22">Cheng, Yi-fei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> yifeicheng1999@vip.sina.cn</i><br /><searchLink fieldCode="AR" term="%22Xiao-jun%2C+Huang%22">Xiao-jun, Huang</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Mar2026, Vol. 67 Issue 4, p846-852. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192477572 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2025.2611117 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 846 Titles: – TitleFull: Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hu, Guan-hua – PersonEntity: Name: NameFull: Zuo, Ying-xi – PersonEntity: Name: NameFull: Zhang, Xiao-hui – PersonEntity: Name: NameFull: Wang, Yu – PersonEntity: Name: NameFull: Xu, Lan-ping – PersonEntity: Name: NameFull: Xin-lin, Hou – PersonEntity: Name: NameFull: Cheng, Yi-fei – PersonEntity: Name: NameFull: Xiao-jun, Huang IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 10428194 Numbering: – Type: volume Value: 67 – Type: issue Value: 4 Titles: – TitleFull: Leukemia & Lymphoma Type: main |
| ResultId | 1 |
